Hairui Sun1,2,3, Xiaoyan Hao1,2, Xin Wang1,2, Xiaoxue Zhou1,2, Ye Zhang1,2, Xiaowei Liu1,2, Jiancheng Han1,2, Xiaoyan Gu1,2, Lin Sun1,2, Ying Zhao1,2, Tong Yi1,2, Hongjia Zhang1,3, Yihua He1,2,3. 1. Beijing Anzhen Hospital, Capital Medical University, Beijing, China. 2. Beijing Key Laboratory of Maternal-Fetal Medicine and Fetal Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. 3. Key Laboratory of Medical Engineering for Cardiovascular Disease, Ministry of Education, Beijing, China.
Abstract
Objectives: Noncompaction Cardiomyopathy (NCCM) has been classified as primary genetic cardiomyopathy and has gained increasing clinical awareness; however, little is known about NCCM in the fetal population. We aimed to investigate the clinical characteristics and genetic spectrum of a fetal population with NCCM. Methods: We retrospectively reviewed all fetuses with a prenatal diagnosis of NCCM at a single center between October 2010 and December 2019. These cases were investigated for gestational age at diagnosis, gender, left or biventricular involvement, associated cardiac phenotypes, outcomes, and genetic testing data. Results: We identified 37 fetuses with NCCM out of 49,898 fetuses, indicating that the incidence of NCCM in the fetal population was 0.07%. Of the 37 fetuses, 26 were male, ten were female and one was of unknown gender. NCCM involvement biventricle is the most common (n = 16, 43%), followed by confined to the left ventricle (n = 14, 38%). Nineteen (51%) had additional congenital heart defects, with right-sided lesions being the most common (n = 14, 74%), followed by ventricular septal defects (n = 10, 53%). Hydrops fetalis was present in 12 cases (32%), of which four were atypical (pericardial effusion only). Sequencing analysis was performed at autopsy (n = 19) or postnatally (n = 1) on 20 fetuses. Of the 20 fetuses undergoing copy number variation sequencing and whole-exome sequencing, nine (47%) had positive genetic results, including one with a pathogenic copy number variant and eight with pathogenic/likely pathogenic variants. Non-sarcomere gene mutations accounted for the vast majority (n = 7). In contrast, sarcomere gene mutations occurred in only one case (TPM1), and no mutations were identified in the three most common sarcomere genes (MYH7, TTN, and MYBPC3) of pediatric and adult patients. Pathogenic/likely pathogenic variants were significantly more frequent in fetuses with congenital heart defects than those without congenital heart defects. Conclusions: Our data demonstrate that fetal NCCM is a unique entity. Compared with pediatric and adult NCCM, fetal NCCM is more prone to biventricle involvement, more likely to be complicated with congenital heart defects, and has a distinct genetic spectrum.
Objectives: Noncompaction Cardiomyopathy (NCCM) has been classified as primary genetic cardiomyopathy and has gained increasing clinical awareness; however, little is known about NCCM in the fetal population. We aimed to investigate the clinical characteristics and genetic spectrum of a fetal population with NCCM. Methods: We retrospectively reviewed all fetuses with a prenatal diagnosis of NCCM at a single center between October 2010 and December 2019. These cases were investigated for gestational age at diagnosis, gender, left or biventricular involvement, associated cardiac phenotypes, outcomes, and genetic testing data. Results: We identified 37 fetuses with NCCM out of 49,898 fetuses, indicating that the incidence of NCCM in the fetal population was 0.07%. Of the 37 fetuses, 26 were male, ten were female and one was of unknown gender. NCCM involvement biventricle is the most common (n = 16, 43%), followed by confined to the left ventricle (n = 14, 38%). Nineteen (51%) had additional congenital heart defects, with right-sided lesions being the most common (n = 14, 74%), followed by ventricular septal defects (n = 10, 53%). Hydrops fetalis was present in 12 cases (32%), of which four were atypical (pericardial effusion only). Sequencing analysis was performed at autopsy (n = 19) or postnatally (n = 1) on 20 fetuses. Of the 20 fetuses undergoing copy number variation sequencing and whole-exome sequencing, nine (47%) had positive genetic results, including one with a pathogenic copy number variant and eight with pathogenic/likely pathogenic variants. Non-sarcomere gene mutations accounted for the vast majority (n = 7). In contrast, sarcomere gene mutations occurred in only one case (TPM1), and no mutations were identified in the three most common sarcomere genes (MYH7, TTN, and MYBPC3) of pediatric and adult patients. Pathogenic/likely pathogenic variants were significantly more frequent in fetuses with congenital heart defects than those without congenital heart defects. Conclusions: Our data demonstrate that fetal NCCM is a unique entity. Compared with pediatric and adult NCCM, fetal NCCM is more prone to biventricle involvement, more likely to be complicated with congenital heart defects, and has a distinct genetic spectrum.
Authors: Preeti Ramachandran; Jessica G Woo; Thomas D Ryan; Roosevelt Bryant; Haleh C Heydarian; John L Jefferies; Jeffrey A Towbin; Angela Lorts Journal: Pediatr Cardiol Date: 2016-06-29 Impact factor: 1.655
Authors: Daryl A Scott; Andres Hernandez-Garcia; Mahshid S Azamian; Valerie K Jordan; Bum Jun Kim; Molly Starkovich; Jinglan Zhang; Lee-Jun Wong; Sandra A Darilek; Amy M Breman; Yaping Yang; James R Lupski; Amyn K Jiwani; Bibhuti Das; Seema R Lalani; Alejandro D Iglesias; Jill A Rosenfeld; Fan Xia Journal: J Med Genet Date: 2016-08-22 Impact factor: 6.318
Authors: S Liu; L Song; D S Cram; L Xiong; K Wang; R Wu; J Liu; K Deng; B Jia; M Zhong; F Yang Journal: Ultrasound Obstet Gynecol Date: 2015-10 Impact factor: 7.299
Authors: Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm Journal: Genet Med Date: 2015-03-05 Impact factor: 8.822
Authors: Erin Rooney Riggs; Erica F Andersen; Athena M Cherry; Sibel Kantarci; Hutton Kearney; Ankita Patel; Gordana Raca; Deborah I Ritter; Sarah T South; Erik C Thorland; Daniel Pineda-Alvarez; Swaroop Aradhya; Christa Lese Martin Journal: Genet Med Date: 2019-11-06 Impact factor: 8.822
Authors: Farbod Sedaghat-Hamedani; Jan Haas; Feng Zhu; Christian Geier; Elham Kayvanpour; Martin Liss; Alan Lai; Karen Frese; Regina Pribe-Wolferts; Ali Amr; Daniel Tian Li; Omid Shirvani Samani; Avisha Carstensen; Diana Martins Bordalo; Marion Müller; Christine Fischer; Jing Shao; Jing Wang; Ming Nie; Li Yuan; Sabine Haßfeld; Christine Schwartz; Min Zhou; Zihua Zhou; Yanwen Shu; Min Wang; Kai Huang; Qiutang Zeng; Longxian Cheng; Tobias Fehlmann; Philipp Ehlermann; Andreas Keller; Christoph Dieterich; Katrin Streckfuß-Bömeke; Yuhua Liao; Michael Gotthardt; Hugo A Katus; Benjamin Meder Journal: Eur Heart J Date: 2017-12-07 Impact factor: 29.983
Authors: Jesús Arnulfo Velásquez-Penagos; Ana María Flórez-Ríos; Edison Muñoz-Ortiz; Jairo Alfonso Gándara-Ricardo; Juan Pablo Flórez-Muñoz; Erika Holguín-González Journal: Rev Colomb Obstet Ginecol Date: 2021-09-30